| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.24B | +38.1% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | +16.0% |
| Gross margin | 19.3% | Net margin 5.0% |
| Revenue Q/Q | -10.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 80.7% |
| R&D | ¥0.01B | 3.8% |
| SG&A | ¥0.02B | 9.2% |
| Tax & other | ¥0.00B | 0.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
恒宇信通 ・ 共同药业 ・ 晓鸣股份 ・ 格林精密 ・ 恒帅股份 ・ 华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子 ・ 达瑞电子 ・ 深圳瑞捷
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies